General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Ionis(MODEST), Novartis Corporation(MODEST), Amryt(MODEST), Endless Health(NONE), partnership for health analytics research(MODEST) OTHER FINANCIAL BENEFIT: GenInCode(NONE)

View Full Disclosure